Latest Breaking News On - Thomas roborel de climens - Page 8 : comparemela.com
Kaufman & Broad SA: H1 2021 Results -2-
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Kaufman & Broad SA: H1 2021 Results -3-
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Kaufman & Broad SA: H1 2021 Results -4-
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
(1)
DJ Affluent Medical announces the success of its initial public offering on the Euronext Paris regulated market.
Affluent Medical
Affluent Medical announces the success of its initial public offering on the Euronext Paris regulated market.
09-Jun-2021 / 20:12 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
PRESS RELEASE
Aix-en-Provence, 9 June 2021 - 8.00 p.m.
AFFLUENT MEDICAL announces the success of its initial public offering on the Euronext Paris regulated market - Capital increase of EUR25 million - IPO price set at EUR8.60 per share - Market capitalisation of approximately EUR156 million
Affluent Medical announces the success of its -2-
DJ Affluent Medical announces the success of its initial public offering on the Euronext Paris regulated market.
Affluent Medical
Affluent Medical announces the success of its initial public offering on the Euronext Paris regulated market.
09-Jun-2021 / 20:12 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
PRESS RELEASE
Aix-en-Provence, 9 June 2021 - 8.00 p.m.
AFFLUENT MEDICAL announces the success of its initial public offering on the Euronext Paris regulated market - Capital increase of EUR25 million - IPO price set at EUR8.60 per share